nodes	percent_of_prediction	percent_of_DWPC	metapath
Tirofiban—Frank hematuria—Tretinoin—peripheral nervous system neoplasm	0.0791	0.161	CcSEcCtD
Tirofiban—Frank hematuria—Isotretinoin—peripheral nervous system neoplasm	0.0791	0.161	CcSEcCtD
Tirofiban—Frank hematuria—Alitretinoin—peripheral nervous system neoplasm	0.0599	0.122	CcSEcCtD
Tirofiban—ITGA2B—Hematopoietic Stem Cell Differentiation—MXI1—peripheral nervous system neoplasm	0.0488	0.0957	CbGpPWpGaD
Tirofiban—ITGB3—Hematopoietic Stem Cell Differentiation—MXI1—peripheral nervous system neoplasm	0.0376	0.0737	CbGpPWpGaD
Tirofiban—ITGA2B—Signal transduction by L1—NCAM1—peripheral nervous system neoplasm	0.0277	0.0543	CbGpPWpGaD
Tirofiban—ITGB3—Signal transduction by L1—NCAM1—peripheral nervous system neoplasm	0.0213	0.0418	CbGpPWpGaD
Tirofiban—ITGB3—Osteoclast Signaling—IFNB1—peripheral nervous system neoplasm	0.0208	0.0408	CbGpPWpGaD
Tirofiban—ITGA2B—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.0168	0.0329	CbGpPWpGaD
Tirofiban—ITGB3—PECAM1 interactions—PTPN11—peripheral nervous system neoplasm	0.0147	0.0289	CbGpPWpGaD
Tirofiban—ITGB3—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.0129	0.0254	CbGpPWpGaD
Tirofiban—ITGA2B—ECM proteoglycans—NCAM1—peripheral nervous system neoplasm	0.0128	0.0251	CbGpPWpGaD
Tirofiban—ITGB3—Monoamine Transport—TH—peripheral nervous system neoplasm	0.0118	0.0233	CbGpPWpGaD
Tirofiban—ITGA2B—Arf6 signaling events—HGF—peripheral nervous system neoplasm	0.0111	0.0218	CbGpPWpGaD
Tirofiban—ITGB3—ECM proteoglycans—NCAM1—peripheral nervous system neoplasm	0.00986	0.0194	CbGpPWpGaD
Tirofiban—ITGA2B—Arf6 signaling events—MET—peripheral nervous system neoplasm	0.00878	0.0172	CbGpPWpGaD
Tirofiban—ITGB3—Arf6 signaling events—HGF—peripheral nervous system neoplasm	0.00858	0.0168	CbGpPWpGaD
Tirofiban—ITGA2B—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.0082	0.0161	CbGpPWpGaD
Tirofiban—ITGB3—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—HGF—peripheral nervous system neoplasm	0.00741	0.0145	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet degranulation—KNG1—peripheral nervous system neoplasm	0.0069	0.0135	CbGpPWpGaD
Tirofiban—ITGB3—Arf6 signaling events—MET—peripheral nervous system neoplasm	0.00676	0.0133	CbGpPWpGaD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	0.00657	0.0129	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00634	0.0124	CbGpPWpGaD
Tirofiban—ITGB3—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00631	0.0124	CbGpPWpGaD
Tirofiban—Hypercholesterolaemia—Tretinoin—peripheral nervous system neoplasm	0.00602	0.0123	CcSEcCtD
Tirofiban—Hypercholesterolaemia—Isotretinoin—peripheral nervous system neoplasm	0.00602	0.0123	CcSEcCtD
Tirofiban—ITGA2B—Platelet degranulation—HGF—peripheral nervous system neoplasm	0.00575	0.0113	CbGpPWpGaD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	0.00547	0.0107	CbGpPWpGaD
Tirofiban—ITGB3—Platelet degranulation—KNG1—peripheral nervous system neoplasm	0.00531	0.0104	CbGpPWpGaD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	0.00506	0.00993	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00489	0.00959	CbGpPWpGaD
Tirofiban—Swelling—Isotretinoin—peripheral nervous system neoplasm	0.00469	0.00955	CcSEcCtD
Tirofiban—Swelling—Tretinoin—peripheral nervous system neoplasm	0.00469	0.00955	CcSEcCtD
Tirofiban—Hypercholesterolaemia—Alitretinoin—peripheral nervous system neoplasm	0.00456	0.0093	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00453	0.00888	CbGpPWpGaD
Tirofiban—ITGB3—Platelet degranulation—HGF—peripheral nervous system neoplasm	0.00443	0.00869	CbGpPWpGaD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	0.00422	0.00828	CbGpPWpGaD
Tirofiban—ITGB3—Integrins in angiogenesis—PTPN11—peripheral nervous system neoplasm	0.00391	0.00767	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin alphaIIb beta3 signaling—AKT1—peripheral nervous system neoplasm	0.00388	0.00762	CbGpPWpGaD
Tirofiban—ITGB3—Signaling events mediated by VEGFR1 and VEGFR2—PTPN11—peripheral nervous system neoplasm	0.00368	0.00722	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—NCAM1—peripheral nervous system neoplasm	0.00365	0.00716	CbGpPWpGaD
Tirofiban—Swelling—Alitretinoin—peripheral nervous system neoplasm	0.00355	0.00724	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00349	0.00684	CbGpPWpGaD
Tirofiban—Myocardial infarction—Tretinoin—peripheral nervous system neoplasm	0.00312	0.00637	CcSEcCtD
Tirofiban—Myocardial infarction—Isotretinoin—peripheral nervous system neoplasm	0.00312	0.00637	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.0031	0.00608	CbGpPWpGaD
Tirofiban—Sweating—Topotecan—peripheral nervous system neoplasm	0.00308	0.00628	CcSEcCtD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	0.00306	0.006	CbGpPWpGaD
Tirofiban—Sweating—Tretinoin—peripheral nervous system neoplasm	0.00305	0.00623	CcSEcCtD
Tirofiban—Sweating—Isotretinoin—peripheral nervous system neoplasm	0.00305	0.00623	CcSEcCtD
Tirofiban—Haematuria—Isotretinoin—peripheral nervous system neoplasm	0.00304	0.00619	CcSEcCtD
Tirofiban—Haematuria—Tretinoin—peripheral nervous system neoplasm	0.00304	0.00619	CcSEcCtD
Tirofiban—ITGA2B—Platelet Aggregation (Plug Formation)—AKT1—peripheral nervous system neoplasm	0.00302	0.00592	CbGpPWpGaD
Tirofiban—ITGB3—Integrin alphaIIb beta3 signaling—AKT1—peripheral nervous system neoplasm	0.00299	0.00587	CbGpPWpGaD
Tirofiban—Haemoglobin—Topotecan—peripheral nervous system neoplasm	0.0029	0.00591	CcSEcCtD
Tirofiban—Haemorrhage—Topotecan—peripheral nervous system neoplasm	0.00288	0.00588	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—HGF—peripheral nervous system neoplasm	0.00288	0.00564	CbGpPWpGaD
Tirofiban—Haemoglobin—Tretinoin—peripheral nervous system neoplasm	0.00287	0.00586	CcSEcCtD
Tirofiban—Haemoglobin—Isotretinoin—peripheral nervous system neoplasm	0.00287	0.00586	CcSEcCtD
Tirofiban—Haemorrhage—Tretinoin—peripheral nervous system neoplasm	0.00286	0.00583	CcSEcCtD
Tirofiban—Haemorrhage—Isotretinoin—peripheral nervous system neoplasm	0.00286	0.00583	CcSEcCtD
Tirofiban—Haemoglobin—Melphalan—peripheral nervous system neoplasm	0.00284	0.00578	CcSEcCtD
Tirofiban—Haemorrhage—Melphalan—peripheral nervous system neoplasm	0.00282	0.00575	CcSEcCtD
Tirofiban—ITGB3—Extracellular matrix organization—NCAM1—peripheral nervous system neoplasm	0.00281	0.00552	CbGpPWpGaD
Tirofiban—Swelling—Etoposide—peripheral nervous system neoplasm	0.00277	0.00565	CcSEcCtD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—PTPN11—peripheral nervous system neoplasm	0.00272	0.00534	CbGpPWpGaD
Tirofiban—Haematemesis—Epirubicin—peripheral nervous system neoplasm	0.00272	0.00554	CcSEcCtD
Tirofiban—Chills—Topotecan—peripheral nervous system neoplasm	0.00259	0.00527	CcSEcCtD
Tirofiban—Chills—Tretinoin—peripheral nervous system neoplasm	0.00257	0.00523	CcSEcCtD
Tirofiban—Chills—Isotretinoin—peripheral nervous system neoplasm	0.00257	0.00523	CcSEcCtD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—PTPN11—peripheral nervous system neoplasm	0.00256	0.00502	CbGpPWpGaD
Tirofiban—Haemoptysis—Epirubicin—peripheral nervous system neoplasm	0.00255	0.0052	CcSEcCtD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	0.00255	0.005	CbGpPWpGaD
Tirofiban—Haematemesis—Doxorubicin—peripheral nervous system neoplasm	0.00251	0.00513	CcSEcCtD
Tirofiban—ITGB3—Signaling by VEGF—PTPN11—peripheral nervous system neoplasm	0.00242	0.00474	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00239	0.00468	CbGpPWpGaD
Tirofiban—Myocardial infarction—Alitretinoin—peripheral nervous system neoplasm	0.00237	0.00482	CcSEcCtD
Tirofiban—Haemoptysis—Doxorubicin—peripheral nervous system neoplasm	0.00236	0.00481	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	0.00236	0.00463	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—MET—peripheral nervous system neoplasm	0.00234	0.00459	CbGpPWpGaD
Tirofiban—ITGB3—Platelet Aggregation (Plug Formation)—AKT1—peripheral nervous system neoplasm	0.00232	0.00456	CbGpPWpGaD
Tirofiban—Sweating—Alitretinoin—peripheral nervous system neoplasm	0.00231	0.00472	CcSEcCtD
Tirofiban—Haematuria—Alitretinoin—peripheral nervous system neoplasm	0.0023	0.00469	CcSEcCtD
Tirofiban—ITGA2B—Signaling events mediated by PTP1B—AKT1—peripheral nervous system neoplasm	0.0023	0.00451	CbGpPWpGaD
Tirofiban—Myocardial infarction—Vincristine—peripheral nervous system neoplasm	0.00228	0.00465	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—MET—peripheral nervous system neoplasm	0.00227	0.00445	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—PTPN11—peripheral nervous system neoplasm	0.00226	0.00443	CbGpPWpGaD
Tirofiban—Sweating—Vincristine—peripheral nervous system neoplasm	0.00223	0.00455	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—HGF—peripheral nervous system neoplasm	0.00222	0.00435	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.00221	0.00434	CbGpPWpGaD
Tirofiban—Haemoglobin—Alitretinoin—peripheral nervous system neoplasm	0.00218	0.00444	CcSEcCtD
Tirofiban—Haemorrhage—Alitretinoin—peripheral nervous system neoplasm	0.00217	0.00442	CcSEcCtD
Tirofiban—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.00215	0.00438	CcSEcCtD
Tirofiban—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.00215	0.00438	CcSEcCtD
Tirofiban—Chills—Dactinomycin—peripheral nervous system neoplasm	0.0021	0.00428	CcSEcCtD
Tirofiban—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00205	0.00418	CcSEcCtD
Tirofiban—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00203	0.00414	CcSEcCtD
Tirofiban—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00203	0.00414	CcSEcCtD
Tirofiban—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.00203	0.00414	CcSEcCtD
Tirofiban—Oedema—Tretinoin—peripheral nervous system neoplasm	0.00203	0.00414	CcSEcCtD
Tirofiban—Myocardial infarction—Cisplatin—peripheral nervous system neoplasm	0.00202	0.00411	CcSEcCtD
Tirofiban—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00201	0.00409	CcSEcCtD
Tirofiban—Oedema—Melphalan—peripheral nervous system neoplasm	0.00201	0.00409	CcSEcCtD
Tirofiban—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.00201	0.00409	CcSEcCtD
Tirofiban—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.00199	0.00406	CcSEcCtD
Tirofiban—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.00199	0.00406	CcSEcCtD
Tirofiban—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.00198	0.00404	CcSEcCtD
Tirofiban—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.00196	0.004	CcSEcCtD
Tirofiban—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.00196	0.004	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	0.00196	0.00385	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.00196	0.004	CcSEcCtD
Tirofiban—Chills—Alitretinoin—peripheral nervous system neoplasm	0.00194	0.00396	CcSEcCtD
Tirofiban—Bradycardia—Cisplatin—peripheral nervous system neoplasm	0.00188	0.00383	CcSEcCtD
Tirofiban—Myocardial infarction—Etoposide—peripheral nervous system neoplasm	0.00185	0.00377	CcSEcCtD
Tirofiban—ITGB3—Signaling events mediated by PTP1B—AKT1—peripheral nervous system neoplasm	0.00177	0.00347	CbGpPWpGaD
Tirofiban—Pain—Topotecan—peripheral nervous system neoplasm	0.00175	0.00357	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—MET—peripheral nervous system neoplasm	0.00175	0.00343	CbGpPWpGaD
Tirofiban—Pain—Tretinoin—peripheral nervous system neoplasm	0.00174	0.00354	CcSEcCtD
Tirofiban—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00174	0.00354	CcSEcCtD
Tirofiban—Pain—Melphalan—peripheral nervous system neoplasm	0.00171	0.0035	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.0017	0.00334	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.0017	0.00334	CbGpPWpGaD
Tirofiban—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00166	0.00339	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—ERBB2—peripheral nervous system neoplasm	0.00166	0.00325	CbGpPWpGaD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—NRAS—peripheral nervous system neoplasm	0.00164	0.00321	CbGpPWpGaD
Tirofiban—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00163	0.00332	CcSEcCtD
Tirofiban—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00163	0.00332	CcSEcCtD
Tirofiban—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00163	0.00331	CcSEcCtD
Tirofiban—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00162	0.0033	CcSEcCtD
Tirofiban—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00161	0.00329	CcSEcCtD
Tirofiban—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00161	0.00329	CcSEcCtD
Tirofiban—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00161	0.00327	CcSEcCtD
Tirofiban—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00161	0.00327	CcSEcCtD
Tirofiban—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00159	0.00325	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—KNG1—peripheral nervous system neoplasm	0.00158	0.0031	CbGpPWpGaD
Tirofiban—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00157	0.0032	CcSEcCtD
Tirofiban—ITGA2B—Integrin-mediated Cell Adhesion—HRAS—peripheral nervous system neoplasm	0.00154	0.00303	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00154	0.00314	CcSEcCtD
Tirofiban—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00154	0.00314	CcSEcCtD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—NRAS—peripheral nervous system neoplasm	0.00154	0.00302	CbGpPWpGaD
Tirofiban—ITGB3—IL4-mediated signaling events—AKT1—peripheral nervous system neoplasm	0.00154	0.00302	CbGpPWpGaD
Tirofiban—ITGB3—Integrins in angiogenesis—AKT1—peripheral nervous system neoplasm	0.00152	0.00298	CbGpPWpGaD
Tirofiban—Chills—Etoposide—peripheral nervous system neoplasm	0.00152	0.00309	CcSEcCtD
Tirofiban—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00151	0.00308	CcSEcCtD
Tirofiban—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00151	0.00307	CcSEcCtD
Tirofiban—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.0015	0.00305	CcSEcCtD
Tirofiban—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.0015	0.00305	CcSEcCtD
Tirofiban—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00149	0.00303	CcSEcCtD
Tirofiban—Oedema—Vincristine—peripheral nervous system neoplasm	0.00148	0.00302	CcSEcCtD
Tirofiban—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00148	0.00302	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—MET—peripheral nervous system neoplasm	0.00148	0.00291	CbGpPWpGaD
Tirofiban—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00148	0.00301	CcSEcCtD
Tirofiban—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00145	0.00296	CcSEcCtD
Tirofiban—ITGB3—Signaling by VEGF—NRAS—peripheral nervous system neoplasm	0.00145	0.00285	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00143	0.00292	CcSEcCtD
Tirofiban—ITGB3—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—peripheral nervous system neoplasm	0.00143	0.0028	CbGpPWpGaD
Tirofiban—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00142	0.0029	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—GNAS—peripheral nervous system neoplasm	0.00138	0.00271	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.00137	0.00269	CbGpPWpGaD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—AKT1—peripheral nervous system neoplasm	0.00136	0.00268	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin-mediated Cell Adhesion—AKT1—peripheral nervous system neoplasm	0.00136	0.00267	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—NRAS—peripheral nervous system neoplasm	0.00136	0.00267	CbGpPWpGaD
Tirofiban—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00135	0.00276	CcSEcCtD
Tirofiban—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00134	0.00274	CcSEcCtD
Tirofiban—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00134	0.00274	CcSEcCtD
Tirofiban—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00132	0.00268	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—HGF—peripheral nervous system neoplasm	0.00131	0.00258	CbGpPWpGaD
Tirofiban—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00131	0.00268	CcSEcCtD
Tirofiban—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00131	0.00267	CcSEcCtD
Tirofiban—Oedema—Cisplatin—peripheral nervous system neoplasm	0.00131	0.00267	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.00131	0.00257	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00128	0.00262	CcSEcCtD
Tirofiban—Headache—Topotecan—peripheral nervous system neoplasm	0.00128	0.00262	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—ERBB2—peripheral nervous system neoplasm	0.00128	0.00251	CbGpPWpGaD
Tirofiban—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00127	0.00259	CcSEcCtD
Tirofiban—Headache—Tretinoin—peripheral nervous system neoplasm	0.00127	0.00259	CcSEcCtD
Tirofiban—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00127	0.00259	CcSEcCtD
Tirofiban—Pain—Vincristine—peripheral nervous system neoplasm	0.00127	0.00259	CcSEcCtD
Tirofiban—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00127	0.00259	CcSEcCtD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—MYC—peripheral nervous system neoplasm	0.00127	0.00248	CbGpPWpGaD
Tirofiban—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00122	0.00249	CcSEcCtD
Tirofiban—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00122	0.00249	CcSEcCtD
Tirofiban—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00122	0.00248	CcSEcCtD
Tirofiban—Nausea—Topotecan—peripheral nervous system neoplasm	0.00122	0.00248	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—KNG1—peripheral nervous system neoplasm	0.00121	0.00238	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—MYC—peripheral nervous system neoplasm	0.00121	0.00238	CbGpPWpGaD
Tirofiban—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00121	0.00246	CcSEcCtD
Tirofiban—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00121	0.00246	CcSEcCtD
Tirofiban—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.0012	0.00245	CcSEcCtD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—HRAS—peripheral nervous system neoplasm	0.0012	0.00235	CbGpPWpGaD
Tirofiban—Nausea—Melphalan—peripheral nervous system neoplasm	0.00119	0.00243	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.00119	0.00234	CbGpPWpGaD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—HRAS—peripheral nervous system neoplasm	0.00119	0.00233	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00118	0.0024	CcSEcCtD
Tirofiban—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00117	0.00239	CcSEcCtD
Tirofiban—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00116	0.00237	CcSEcCtD
Tirofiban—ITGA2B—Extracellular matrix organization—CASP3—peripheral nervous system neoplasm	0.00116	0.00227	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.00114	0.00224	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—MET—peripheral nervous system neoplasm	0.00114	0.00224	CbGpPWpGaD
Tirofiban—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00113	0.00231	CcSEcCtD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—HRAS—peripheral nervous system neoplasm	0.00113	0.00221	CbGpPWpGaD
Tirofiban—Pain—Cisplatin—peripheral nervous system neoplasm	0.00112	0.00229	CcSEcCtD
Tirofiban—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00109	0.00223	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.00108	0.00212	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—HRAS—peripheral nervous system neoplasm	0.00106	0.00209	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—GNAS—peripheral nervous system neoplasm	0.00106	0.00209	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—MET—peripheral nervous system neoplasm	0.00106	0.00207	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.00105	0.00207	CbGpPWpGaD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—AKT1—peripheral nervous system neoplasm	0.00105	0.00206	CbGpPWpGaD
Tirofiban—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00104	0.00211	CcSEcCtD
Tirofiban—Pain—Etoposide—peripheral nervous system neoplasm	0.00103	0.0021	CcSEcCtD
Tirofiban—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00208	CcSEcCtD
Tirofiban—Sweating—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00206	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—HGF—peripheral nervous system neoplasm	0.00101	0.00199	CbGpPWpGaD
Tirofiban—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00205	CcSEcCtD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—TP53—peripheral nervous system neoplasm	0.000995	0.00195	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—HRAS—peripheral nervous system neoplasm	0.000994	0.00195	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—AKT1—peripheral nervous system neoplasm	0.000994	0.00195	CbGpPWpGaD
Tirofiban—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000986	0.00201	CcSEcCtD
Tirofiban—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000981	0.002	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000977	0.00192	CbGpPWpGaD
Tirofiban—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000966	0.00197	CcSEcCtD
Tirofiban—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000965	0.00197	CcSEcCtD
Tirofiban—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000965	0.00197	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.000958	0.00188	CbGpPWpGaD
Tirofiban—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000955	0.00195	CcSEcCtD
Tirofiban—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000953	0.00194	CcSEcCtD
Tirofiban—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00095	0.00194	CcSEcCtD
Tirofiban—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000948	0.00193	CcSEcCtD
Tirofiban—ITGB3—Signaling by VEGF—AKT1—peripheral nervous system neoplasm	0.000938	0.00184	CbGpPWpGaD
Tirofiban—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000937	0.00191	CcSEcCtD
Tirofiban—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000932	0.0019	CcSEcCtD
Tirofiban—Headache—Vincristine—peripheral nervous system neoplasm	0.000929	0.0019	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—HRAS—peripheral nervous system neoplasm	0.000923	0.00181	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000917	0.0018	CbGpPWpGaD
Tirofiban—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000915	0.00186	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000902	0.00177	CbGpPWpGaD
Tirofiban—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000893	0.00182	CcSEcCtD
Tirofiban—ITGB3—Extracellular matrix organization—CASP3—peripheral nervous system neoplasm	0.000891	0.00175	CbGpPWpGaD
Tirofiban—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000885	0.00181	CcSEcCtD
Tirofiban—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000882	0.0018	CcSEcCtD
Tirofiban—Nausea—Vincristine—peripheral nervous system neoplasm	0.000881	0.0018	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000879	0.00172	CbGpPWpGaD
Tirofiban—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000877	0.00179	CcSEcCtD
Tirofiban—Chills—Epirubicin—peripheral nervous system neoplasm	0.000851	0.00173	CcSEcCtD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.00084	0.00165	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000834	0.00164	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000832	0.00163	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000823	0.00162	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—AKT1—peripheral nervous system neoplasm	0.000815	0.0016	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—MET—peripheral nervous system neoplasm	0.000814	0.0016	CbGpPWpGaD
Tirofiban—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000795	0.00162	CcSEcCtD
Tirofiban—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000787	0.00161	CcSEcCtD
Tirofiban—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000779	0.00159	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000772	0.00152	CbGpPWpGaD
Tirofiban—Headache—Etoposide—peripheral nervous system neoplasm	0.000753	0.00154	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000753	0.00148	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.000738	0.00145	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	0.000722	0.00142	CbGpPWpGaD
Tirofiban—Nausea—Etoposide—peripheral nervous system neoplasm	0.000714	0.00146	CcSEcCtD
Tirofiban—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000713	0.00145	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—HRAS—peripheral nervous system neoplasm	0.000711	0.0014	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000695	0.00136	CbGpPWpGaD
Tirofiban—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000674	0.00137	CcSEcCtD
Tirofiban—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000674	0.00137	CcSEcCtD
Tirofiban—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00066	0.00134	CcSEcCtD
Tirofiban—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000659	0.00134	CcSEcCtD
Tirofiban—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000651	0.00133	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000641	0.00126	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000634	0.00124	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—AKT1—peripheral nervous system neoplasm	0.000628	0.00123	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000625	0.00123	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000623	0.00127	CcSEcCtD
Tirofiban—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000623	0.00127	CcSEcCtD
Tirofiban—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00061	0.00124	CcSEcCtD
Tirofiban—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000603	0.00123	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000602	0.00118	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000595	0.00117	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000587	0.00115	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—NRAS—peripheral nervous system neoplasm	0.000576	0.00113	CbGpPWpGaD
Tirofiban—Pain—Epirubicin—peripheral nervous system neoplasm	0.000576	0.00117	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	0.000556	0.00109	CbGpPWpGaD
Tirofiban—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000535	0.00109	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000535	0.00105	CbGpPWpGaD
Tirofiban—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000533	0.00109	CcSEcCtD
Tirofiban—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000533	0.00109	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.00051	0.001	CbGpPWpGaD
Tirofiban—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000496	0.00101	CcSEcCtD
Tirofiban—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000495	0.00101	CcSEcCtD
Tirofiban—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000493	0.001	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000482	0.000945	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000468	0.000918	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000464	0.00091	CbGpPWpGaD
Tirofiban—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000459	0.000936	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000453	0.000888	CbGpPWpGaD
Tirofiban—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000445	0.000908	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—NRAS—peripheral nervous system neoplasm	0.000444	0.000871	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—TP53—peripheral nervous system neoplasm	0.000441	0.000865	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.00043	0.000843	CbGpPWpGaD
Tirofiban—Headache—Epirubicin—peripheral nervous system neoplasm	0.000422	0.00086	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—HRAS—peripheral nervous system neoplasm	0.000422	0.000827	CbGpPWpGaD
Tirofiban—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000412	0.00084	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000412	0.000808	CbGpPWpGaD
Tirofiban—Nausea—Epirubicin—peripheral nervous system neoplasm	0.0004	0.000816	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000393	0.00077	CbGpPWpGaD
Tirofiban—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.000796	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000379	0.000745	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—AKT1—peripheral nervous system neoplasm	0.000372	0.000731	CbGpPWpGaD
Tirofiban—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00037	0.000755	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.00036	0.000707	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—TP53—peripheral nervous system neoplasm	0.00034	0.000666	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000331	0.00065	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000325	0.000638	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—HRAS—peripheral nervous system neoplasm	0.000325	0.000637	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000292	0.000574	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—AKT1—peripheral nervous system neoplasm	0.000287	0.000563	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000257	0.000504	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.00025	0.000491	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000233	0.000457	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000198	0.000388	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000195	0.000383	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000182	0.000357	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.00018	0.000352	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000151	0.000295	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000149	0.000293	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000143	0.000281	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.00014	0.000275	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.000126	0.000248	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000115	0.000226	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.00011	0.000216	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.72e-05	0.000191	CbGpPWpGaD
